Primary sclerosing cholangitis overview

Revision as of 15:39, 5 September 2012 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search


Primary sclerosing cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary sclerosing cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary sclerosing cholangitis overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary sclerosing cholangitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary sclerosing cholangitis overview

CDC on Primary sclerosing cholangitis overview

Primary sclerosing cholangitis overview in the news

Blogs on Primary sclerosing cholangitis overview

Directions to Hospitals Treating Primary sclerosing cholangitis

Risk calculators and risk factors for Primary sclerosing cholangitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Primary sclerosing cholangitis (PSC) is a form of cholangitis due to an autoimmune reaction. A cholangitis is an inflammation of the bile ducts of the liver. Primary sclerosing cholangitis leads to cholestasis (blockage of biletransport to the gut). Blockage of the bile duct leads to accumulation of bile, which damages the liver, leading to jaundice and eventually causes liver failure.

References

Template:WH Template:WS